Michael Bloomberg's name was tossed around once as a third-party candidate but his endorsement of Hillary Clinton may backfire, says Breakingviews columnist Rob Cox. » Read More
Traders had been covering shorts ahead of the ruling released Friday, but are re-establishing their positions.
Bridgewater is telling recruitment firms to cancel interviews with prospective employees, according to three people briefed on the matter.
Herb Greenberg, Pacific Crest Research, reacts to FTC Chairwoman Edith Ramirez's announcement.
CNBC's Kate Kelly reports on the settlement between the FTC and Herbalife, and just how much Pershing Square's Bill Ackman is losing.
Shares in the nutritional supplement marketer jumped 10 percent in premarket trading on the news.
Shares of Herbalife are up in the pre-market on word the FTC is expected to announce a settlement today with Herbalife.
Billionaire investor Bill Ackman of Pershing Square accused Citron's Andrew Left of pumping and dumping Valeant's stock on "Fast Money Halftime Report" Thursday. Citron Research executive director Andrew Left, reacts.
Bill Ackman discussed his latest views on Herbalife, Valeant Pharmaceuticals and Mondelez in an extensive interview with CNBC's Scott Wapner on Thursday.
Herb Greenberg, Pacific Square Research Partner, and CNBC's Scott Wapner, discuss Bill Ackman's attack on Herbalife's business model.
He said that while it's likely there will come a day where Valeant sells off its non-core assets, Bausch & Lomb will not be one.
Bill Ackman, Pershing Square CEO, joins "Fast Money Halftime Report" and talks about Herbalife and Valeant.
Some of the names on the move ahead of the open.
Pershing Square Capital Management is laying off eight lower-level employees, sources told Dow Jones.
Carl Icahn and Bill Ackman may have made up after their epic feud, but Icahn still insists Ackman is "totally wrong" for shorting Herbalife.
Billionaire investor Carl Icahn, who made up with Ackman, tells CNBC Herbalife is not a pyramid scheme and it creates jobs.
Jeffrey Sonnenfeld, Yale School of Management provides a preview of this year's CEO summit, where topics such as how to deal with disruption in an election year, Valeant's meltdown, and a bidding war for Yahoo, will be up for discussion.
Christopher Hall recognizes a good market opportunity. He wants to be to sneaker lovers what Bill Ackman is to shareholders.
A group of hedge funds have formed a new lobbying arm to promote the benefits of shareholder activism across the U.S. economy.
Jim Cramer turned to the charts to determine the future of one group that continues to climb higher.
In exclusive content for Pro members, CNBC's Scott Wapner interviews Marc Grow, the winner of the Sohn Investment Idea Contest.